Vanguard Group Inc Rani Therapeutics Holdings, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 709,828 shares of RANI stock, worth $1.04 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
709,828
Previous 709,828
-0.0%
Holding current value
$1.04 Million
Previous $1.53 Million
36.59%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding RANI
# of Institutions
47Shares Held
3.68MCall Options Held
44KPut Options Held
193K-
Nan Fung Group Holdings LTD Central, K3494KShares$725,5680.67% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$659,2830.04% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$445,0320.01% of portfolio
-
Two Sigma Investments, LP New York, NY291KShares$428,3300.0% of portfolio
-
Geode Capital Management, LLC Boston, MA172KShares$252,2120.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $36M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...